EU-Startups Podcast From Google Glass to Dementia Care
Oct 1, 2026
Babak Parviz, founder of NewDays.ai and former Google X and Amazon executive, discusses his journey from Google Glass to dementia care. He explores AI-powered support for patients and families, scaling clinically validated treatments, and AI’s future role alongside clinicians. The conversation also examines aging populations in Europe and Asia, cultural adaptation, healthcare regulation, and why focused startups can move faster than tech giants.
AI Snips
Chapters
Transcript
Episode notes
AI Steps In Where Dementia Drugs Fall Short
- NewDays uses AI to support people with dementia or cognitive impairment, where pharmaceutical options remain limited.
- Recent advances made this intervention feasible, with the goal of delaying symptoms rather than showcasing technology.
From Google Glass To Dementia Care
- Babak Parviz moved from venture capital and Amazon healthcare leadership to dementia care after seeing cognition emerge as a major unmet need.
- His experience also includes building Google Glass at Google X and family connections to Alzheimer’s and dementia.
Dementia Is A System-Wide Crisis
- Cognitive impairment affects roughly one-third of people over 65 and reshapes social life, finances, housing, and broader healthcare.
- Babak Parviz estimates annual extra costs of $18,000 for MCI and $30,000 for dementia in the US.